U.S. Pharmacist Weekly News Update
October 17, 2019

Why Not All Prostate-Cancer Patients Should Get Hormone Therapy After Surgery
Pharmacists routinely dispense hormone therapy to men who have undergone prostate-cancer surgery. Now, a new review of a practice-changing study says that might not be optimal treatment for some patients and could even increase their risk for all-cause mortality. Here is more information.


Teenagers Taking Oral Contraceptives More Likely to Report Depressive Symptoms
Teenagers taking oral contraceptives might need some extra attention. Find out why a new study recommends that pharmacists and other healthcare professionals monitor adolescents who take birth control pills and how depressive symptoms can affect their medication adherence.

Three-in-One Inhaler
Improves Control in
Severe Asthma Patients

Asthma patients whose symptoms remain uncontrolled sometimes have to juggle multiple inhalers, which can have different designs, instructions, and dosing regimens. Find out the results of a study that examined a three-in-one inhaler for adults with severe asthma not controlled by standard treatment.

New Guidelines Seek to
Improve Treatment of
Osteoporosis-Related Fractures

Patients sometimes are wary of treatment of osteoporosis fractures, as pharmacists well know. Now, new guidelines recommend broader use of pharmacotherapies to reduce risk of future fractures, as well as educational efforts to improve patient acceptance. Here are more details.


Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App